Moncyte Health

Provider of diagnostic test for optimal cholesterol-lowering therapy

placeHelsinki, Uusimaa, Finland calendar_todayFounded 2024 language moncytehealth.com

Innovation

1 patent family — focus: Physics & computing; filing pace active.

YearFilings
20241

Social engagement

Social engagement: 2.8K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Inventure.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%

Recent activity

26 May 2026
Event
European Atherosclerosis Society 2026
24 May 2026
Event
EAS2026
Coming soon